CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production

被引:123
作者
Tomer, Y
Greenberg, DA
Barbesino, G
Concepcion, E
Davies, TF
机构
[1] CUNY Mt Sinai Sch Med, Dept Med, Div Endocrinol & Metab, New York, NY 10029 USA
[2] CUNY Mt Sinai Sch Med, Dept Psychiat, Div Endocrinol & Metab, New York, NY 10029 USA
[3] CUNY Mt Sinai Sch Med, Dept Biomath, Div Endocrinol & Metab, New York, NY 10029 USA
关键词
D O I
10.1210/jc.86.4.1687
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
One of the hallmarks of the human autoimmune thyroid diseases (AITDs) is the production of high titers of autoantibodies against thyroglobulin and thyroid peroxidase that often precedes the development of clinical disease. A high percentage of family members of patients with AITDs have significant titers of thyroid antibodies (TAbs), suggesting a genetic predisposition for their development, and segregation analyses have favored a dominant mode of inheritance. The aim of the present study was to identify the susceptibility genes for TAb production. We completed a genome-wide scan in 56 multiplex families (323 individuals) in which all family members with AITDs and/or detectable TAbs were considered affected. The highest a-point logarithm of odds (LOD) score of 3.6 was obtained for marker D2S325 on chromosome 2q33 at 210.9 centimorgans. This locus showed no evidence for linkage to Graves' disease or Hashimoto's thyroiditis (2-point LOD scores, 0.42 for Graves' disease and -0.60 for Hashimoto's thyroiditis), demonstrating that the gene in this region conferred susceptibility to TAbs, but that clinical disease development required additional genetic and/or environmental factors. We then fine-mapped the region linked with TAbs using 11 densely spaced microsatellite markers. Multipoint linkage analysis using these markers showed a maximum LOD score of 4.2 obtained for marker D2S155 at 209.8 centimorgans (with heterogeneity, alpha = 0.41). As the linked region contained the CTLA-4 and CD28 genes, we then tested whether they mere the susceptibility genes for TAbs on chromosome 2q33. The CD28 gene was sequenced in 15 individuals, and a new C/T single nucleotide polymorphism (SNP) was identified in intron 3. Analysis of this SNP revealed no association with TAbs in the probands of the linked families (families that were linked with D2S155) compared with controls. The CTLA-4 gene was analyzed using the known A/G(49) SNP, and the results showed a significantly increased frequency of the G allele in the probands of the linked families compared with the probands of the unlinked families or with controls (P = 0.02). We concluded that 1) a major gene for thyroid autoantibody production was located on chromosome 2q33; 2) the TAb gene on chromosome 2q33 was most likely the CTLA-4 gene and not the CD28 gene; and 3) CTLA-4 contributed to the genetic susceptibility to TAb production, but there was no evidence that it contributed specifically to Graves' or Hashimoto's diseases.
引用
收藏
页码:1687 / 1693
页数:7
相关论文
共 50 条
  • [21] CTLA-4 antagonizes CD28 surface expression on T cells
    Berg, M
    Zavazava, N
    FASEB JOURNAL, 2003, 17 (07) : C62 - C62
  • [22] Molecular cloning and expression of feline CD28 and CTLA-4 cDNA
    Choi, IS
    Hash, SM
    Collisson, EW
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2000, 76 (1-2) : 45 - 59
  • [23] CTLA-4 and CD28 gene polymorphisms influence on kidney and liver allograft survival.
    Marder, BA
    Tomer, Y
    Watschinger, B
    Schiano, T
    Lin, M
    Schroppel, B
    Murphy, B
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 13A - 13A
  • [24] Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population
    Ahmed, S
    Ihara, K
    Kanemitsu, S
    Nakashima, H
    Otsuka, T
    Tsuzaka, K
    Takeuchi, T
    Hara, T
    RHEUMATOLOGY, 2001, 40 (06) : 662 - 667
  • [25] Genetic analysis of the CTLA-4/CD28 gene region in type I diabetes.
    Barreto, M
    Vicente, A
    Vassilevskaya, T
    Duarte, N
    Gardete-Correia, L
    Boavida, J
    Duarte, R
    Raposo, F
    Mendes, J
    Penha-Gonçalves, C
    Holmberg, D
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 574 - 574
  • [26] CD28, CTLA-4 and CCL5 gene polymorphisms in patients with rheumatoid arthritis
    Katarzyna Luterek-Puszyńska
    Damian Malinowski
    Agnieszka Paradowska-Gorycka
    Krzysztof Safranow
    Andrzej Pawlik
    Clinical Rheumatology, 2017, 36 : 1129 - 1135
  • [27] Peptides for elucidating the signal tranduction pathways of CTLA-4 and CD28
    Singleton, DH
    Gardner, JP
    Andrews, GC
    Fisher, TS
    Duerr, JM
    Guarino, BC
    Nunez, D
    Alegre, ML
    Neveu, MJ
    PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 602 - 603
  • [28] CD28, CTLA-4 and their ligands: who does what and to whom?
    Sansom, DM
    IMMUNOLOGY, 2000, 101 (02) : 169 - 177
  • [29] CD28 and CTLA-4 regulation of interleukin-2 production in T-cells.
    Rudd, CE
    Hu, H
    Raab, M
    Cefai, D
    Schneider, H
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 832 - 832
  • [30] CD28, CTLA-4 and CCL5 gene polymorphisms in patients with rheumatoid arthritis
    Luterek-Puszynska, Katarzyna
    Malinowski, Damian
    Paradowska-Gorycka, Agnieszka
    Safranow, Krzysztof
    Pawlik, Andrzej
    CLINICAL RHEUMATOLOGY, 2017, 36 (05) : 1129 - 1135